321 related articles for article (PubMed ID: 23860128)
1. A miR-34a-SIRT6 axis in the squamous cell differentiation network.
Lefort K; Brooks Y; Ostano P; Cario-André M; Calpini V; Guinea-Viniegra J; Albinger-Hegyi A; Hoetzenecker W; Kolfschoten I; Wagner EF; Werner S; Dotto GP
EMBO J; 2013 Aug; 32(16):2248-63. PubMed ID: 23860128
[TBL] [Abstract][Full Text] [Related]
2. miR-34a/SIRT6 in squamous differentiation and cancer.
Dotto GP; Karine L
Cell Cycle; 2014; 13(7):1055-6. PubMed ID: 24583844
[No Abstract] [Full Text] [Related]
3. MiR-34a-5p suppresses cutaneous squamous cell carcinoma progression by targeting SIRT6.
Chen S; Yuan M; Chen H; Wu T; Wu T; Zhang D; Miao X; Shi J
Arch Dermatol Res; 2024 May; 316(6):299. PubMed ID: 38819446
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
[TBL] [Abstract][Full Text] [Related]
6. miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.
Ruan L; Chen J; Ruan L; Tan A; Wang P
Int J Clin Exp Pathol; 2018; 11(3):1135-1145. PubMed ID: 31938208
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601
[TBL] [Abstract][Full Text] [Related]
8. Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Rajkumar KS; Rajaraman R; Munirajan AK
Asian Pac J Cancer Prev; 2015; 16(17):7619-25. PubMed ID: 26625772
[TBL] [Abstract][Full Text] [Related]
9. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
10. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
11. Age-related epigenetic drift deregulates
Owczarz M; Połosak J; Domaszewska-Szostek A; Kołodziej P; Kuryłowicz A; Puzianowska-Kuźnicka M
Epigenetics; 2020 Dec; 15(12):1336-1347. PubMed ID: 32573339
[TBL] [Abstract][Full Text] [Related]
12. miR-34a repression of SIRT1 regulates apoptosis.
Yamakuchi M; Ferlito M; Lowenstein CJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13421-6. PubMed ID: 18755897
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
14. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
15. MiR-34, SIRT1 and p53: the feedback loop.
Yamakuchi M; Lowenstein CJ
Cell Cycle; 2009 Mar; 8(5):712-5. PubMed ID: 19221490
[TBL] [Abstract][Full Text] [Related]
16. miR-203 represses 'stemness' by repressing DeltaNp63.
Lena AM; Shalom-Feuerstein R; Rivetti di Val Cervo P; Aberdam D; Knight RA; Melino G; Candi E
Cell Death Differ; 2008 Jul; 15(7):1187-95. PubMed ID: 18483491
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells.
Chen L; Holmstrøm K; Qiu W; Ditzel N; Shi K; Hokland L; Kassem M
Stem Cells; 2014 Apr; 32(4):902-12. PubMed ID: 24307639
[TBL] [Abstract][Full Text] [Related]
18. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells.
Baker JR; Vuppusetty C; Colley T; Papaioannou AI; Fenwick P; Donnelly L; Ito K; Barnes PJ
Sci Rep; 2016 Oct; 6():35871. PubMed ID: 27767101
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
